Ignite Creation Date:
2024-05-05 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 9:38 AM
Study NCT ID:
NCT00573924
Status:
COMPLETED
Last Update Posted:
2011-02-08
First Post:
2007-12-13
Brief Title:
Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
Sponsor:
University of Southern California
Organization:
University of Southern California
Study Overview
Official Title:
Prospective Randomized Comparison of the Effect of Frequent Oral Dosing Versus Constant IV Infusion of Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients with bleeding ulcers identified by endoscopy will be randomly assigned to receive an acid-blocking drug called a proton pump inhibitor PPI either by mouth every 3 hours for 24 hours or intravenously IV by constant infusion for 24 hours A pH probe in the stomach will be used to determine intragastric pH a measure of the acid production in the stomach at baseline and during the 24 hours of therapy The purpose of the study is to determine if the continuous intravenous administration of the drug provides better reduction of acid in the stomach than the oral administration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HS-06-00014 | None | None | None |